We are live on
!
Find out more
Zurich Cantonal Bank Portfolio holdings
AUM
$46B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$40.9B
AUM Growth
+$6.08B
(+17%)
Cap. Flow
+$2.16B
Cap. Flow
% of AUM
5.29%
Top 10 Holdings %
Top 10 Hldgs %
33.91%
Holding
2,656
New
37
Increased
1,264
Reduced
635
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMRZ
Amrize Ltd
AMRZ
|
+$459M |
| 2 |
Apple
AAPL
|
+$167M |
| 3 |
Microsoft
MSFT
|
+$148M |
| 4 |
NVIDIA
NVDA
|
+$141M |
| 5 |
UBS Group
UBS
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$104M |
| 2 |
CME Group
CME
|
+$92.2M |
| 3 |
Procter & Gamble
PG
|
+$67.1M |
| 4 |
Verizon
VZ
|
+$53.3M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$51.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.17% |
| 2 | Financials | 17.35% |
| 3 | Healthcare | 10.51% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Industrials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
2451
DELISTED
Centessa Pharmaceuticals
CNTA
| $8.96K | ﹤0.01% |
682
-73
| -10% | -$925 |
|
2452
Mercer International
MERC
$38M
| $8.92K | ﹤0.01% |
2,549
| – | – |
|
2453
ArriVent BioPharma
AVBP
$1.43B
| $8.9K | ﹤0.01% |
409
-48
| -11% | -$997 |
|
2454
Zegna
ZGN
$4B
| $7.97K | ﹤0.01% |
932
| – | – |
|
2455
Alvotech
ALVO
$1.28B
| $7.91K | ﹤0.01% |
867
-160
| -16% | -$1.5K |
|
|
OTLY
2456
Oatly Group
OTLY
$440M
| $7.91K | ﹤0.01% |
666
-7
| -1% | -$74 |
|
2457
Monte Rosa Therapeutics
GLUE
$1.35B
| $7.04K | ﹤0.01% |
1,560
-293
| -16% | -$1.31K |
|
2458
Praxis Precision Medicines
PRAX
$9.98B
| $7.02K | ﹤0.01% |
167
| – | – |
|
|
MESO
2459
Mesoblast
MESO
$2.14B
| $6.89K | ﹤0.01% |
633
| – | – |
|
2460
Cartesian Therapeutics
RNAC
$266M
| $6.65K | ﹤0.01% |
640
-72
| -10% | -$767 |
|
2461
Alpha Teknova
TKNO
$348M
| $6.59K | ﹤0.01% |
1,342
-265
| -16% | -$1.56K |
|
2462
Altimmune
ALT
$599M
| $6.24K | ﹤0.01% |
1,612
-14,868
| -90% | -$80.5K |
|
2463
Design Therapeutics
DSGN
$883M
| $6.12K | ﹤0.01% |
1,817
-348
| -16% | -$1.3K |
|
|
ESPR
2464
DELISTED
Esperion Therapeutics
ESPR
| $5.99K | ﹤0.01% |
6,082
| – | – |
|
2465
MaxCyte
MXCT
$126M
| $5.91K | ﹤0.01% |
2,709
-574
| -17% | -$1.39K |
|
|
TECX
2466
Tectonic Therapeutic
TECX
$608M
| $5.62K | ﹤0.01% |
283
| – | – |
|
2467
Codexis
CDXS
$159M
| $5.55K | ﹤0.01% |
2,276
-2,450
| -52% | -$5.75K |
|
2468
Entrada Therapeutics
TRDA
$267M
| $5.01K | ﹤0.01% |
746
| – | – |
|
2469
Omeros
OMER
$960M
| $4.07K | ﹤0.01% |
1,358
| – | – |
|
2470
Beyond Meat
BYND
$286M
| $3.64K | ﹤0.01% |
1,042
-10,840
| -91% | -$31.4K |
|
2471
FuelCell Energy
FCEL
$1.63B
| $2.66K | ﹤0.01% |
474
-123,203
| -100% | -$598K |
|
2472
Pliant Therapeutics
PLRX
$65M
| $1.01K | ﹤0.01% |
871
-8,123
| -90% | -$11.5K |
|
2473
Editas Medicine
EDIT
$435M
| $792 | ﹤0.01% |
360
-6,192
| -95% | -$10.1K |
|
|
CMRC
2474
Commerce.com Inc Series 1
CMRC
$177M
| $770 | ﹤0.01% |
154
-12,819
| -99% | -$66K |
|
2475
Pluri
PLUR
$19.6M
| $673 | ﹤0.01% |
136
| – | – |
|
Similar funds
LP
TI
Zurich Cantonal Bank's Q2 2025 Portfolio in Review
As of Q2 2025, Zurich Cantonal Bank held 2,656 positions worth $40.9B, up 17% from $34.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Zurich Cantonal Bank deployed $2.16B of net new capital in Q2 2025, opening 37 new positions and adding to 1,264 existing holdings. Its largest new stake was Amrize Ltd: 9,097,290 shares worth $452M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $104M trimmed.
- Zurich Cantonal Bank's largest Q2 2025 buy was Amrize Ltd: 9,097,290 shares worth $452M.
- Zurich Cantonal Bank added most to Apple in Q2 2025, an estimated $167M increase.
- Zurich Cantonal Bank's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $104M.
- Zurich Cantonal Bank fully exited Discover Financial Services in Q2 2025, selling an estimated $51.8M.
- Zurich Cantonal Bank's ten largest holdings make up 34% of its $40.9B portfolio in Q2 2025.
- Zurich Cantonal Bank opened 37 new positions and closed 96 in Q2 2025.
- Zurich Cantonal Bank's portfolio value rose 17% quarter-over-quarter to $40.9B.
Based on Zurich Cantonal Bank's 13F filing for Q2 2025, filed 7 Aug 2025.